genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
HIV
Monocytes May Be a Stable Reservoir of HIV
Alzheimers
Study Links High Blood Pressure with Damage to Brain Regions and…
Animal Models
Brain’s White Matter Formation Impacted by Mea6 Antigen Deficiency in Oligodendrocytes
Drug Discovery
Brain Cell Signaling Linked to Yo-Yo Effect of Dieting
Liquid Biopsies
Illumina, Icahn Spar over Board Indemnification for Grail Purchase
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
AgBio
Plants to Play Larger Role in Battle against COVID-19
Bioprocessing
Merck Biomanufacturing Optimization Sees Major Production Gains
Bioprocessing
Pharmaceutical Manufacturers Need to Stay Focused on Supply Chain Audit
Bioprocessing
Cell-Free Synthesis of Peptidomimetic Drugs by International Research Team
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Companies
Biogen
Biogen
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biogen
BMS Licenses mAb and Fusion Protein Drugs to Biogen and to Roche for up to $1B
Biogen
Biogen Acquires Stroke Candidate Cirara from Remedy for $120M Upfront
Biogen
Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s Candidate IONIS-MAPTRx
Biogen
AbbVie Launches, Biogen Tweaks Alzheimer’s Collaborations
Biogen
Biogen to Develop Alkermes’ MS Candidate ALKS 8700
Biogen
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
Biogen
Biogen Halts Development of Tysabri for Acute Ischemic Stroke after Phase...
Biogen
Biogen, AbbVie Withdraw MS Drug Zinbryta after Brain Disorders Spark EMA...
Biogen
Biogen Buys Pfizer Neuropsychiatry Candidate for Up-to-$590M+
Biogen
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
Biogen
Biogen Buys Option to TMS’ Phase II Stroke Candidate
Biogen
Biogen Raising Minority Stake in Samsung Bioepis in $672M Deal
Biogen
“Some Hope”: Biogen, Eisai Release Positive Phase II Results for Alzheimer’s...
Biogen
Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar...
Biogen
Fujifilm Diosynth to Expand with $890M Purchase of Biogen’s Danish Biologics...
1
2
3
Page 1 of 3
Scroll Up